FDA Inspection 1088284 — LifeServe Blood Center

LifeServe Blood Center — FEI 1970344

The FDA completed an inspection of LifeServe Blood Center on April 5, 2019 in Sioux City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 5, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sioux City, IA (United States)